Current evidence suggests that PKR accumulates in the brain and cerebrospinal fluid in patients with AD and mild cognitive impairment, leading to TNFα and IL1-β production (Hugon et al., 2017). The gene discussed is EIF2AK2; the disease is Alzheimer disease.